Evidence map›Paper›PMID 39853560›Full record

ArticleClinical rheumatology2025

Clinical features of inflammatory arthritis in daily practice-China's perspective.

Wenwen Pei, Liling Xu, Hua Zhong, Ziye Wang, Ranran Yao, Lei Zhang, Jing Yang, Jingyang Li, Yuan Feng, Qi Lin and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Wenwen Pei *Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China.
Liling Xu *Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China.
Hua ZhongDepartment of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China.
Ziye WangDepartment of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China.
Ranran YaoDepartment of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China.
Lei ZhangDepartment of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jing YangDepartment of Rheumatology and Immunology, Mianyang Central Hospital, Mianyang, China.
Jingyang LiDepartment of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, China.
Yuan FengDepartment of Rheumatology and Immunology, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Qi LinDepartment of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, China.
Dongsheng LiDepartment of Rheumatology, Ganzhou People's Hospital, Ganzhou, China.
Xinyao ZhouDivision of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Dongxue PeiDepartment of Rheumatology, Jilin Hospital of Integrated Traditional Chinese and Western Medicine, Jilin, China.
Yanqiu GuoDepartment of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li MaDepartment of Rheumatology, China-Japan Friendship Hospital, Beijing, China.
Yaping LuoDepartment of Rheumatology, Hebei Provincial Hospital of Traditional Chinese Medicine, Hebei, China.
Shufei ZuoDepartment of Rheumatology and Immunology, Xinxiang Central Hospital, Xinxiang, China.
Lin WangDepartment of Rheumatology, Shaoyang Central Hospital, Shaoyang, China.
Rui YanDepartment of Rheumatology and Immunology, Beijing Shunyi Hospital, Beijing, China.
Yin SuDepartment of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, 100044, China. suyin@pkuph.edu.cn.ORCID http://orcid.org/0009-0001-5444-3435

Funding

Beijing Science and Technology Planning Project Z191100006619111National Natural Science Foundation of China 81871290National Natural Science Foundation of China 8223000963Peking University People's Hospital Research and Development Funds RS2022-04
6 · The paper itself

Abstract

objectiveThis study aimed to analyze and compare the proportion of patients with different types of inflammatory arthritis and investigate the clinical characteristics, including symptoms and signs, medication choices, and disease activity, in the daily clinical practice of China.

methodsPatients with inflammatory arthritis were recruited from 16 Grade-A tertiary hospitals between August 2021 and April 2022. The medical profiles, encompassing sociodemographic characteristics, clinical and laboratory date, were collected.

resultsThis study included 2,693 patients with arthritis, with rheumatoid arthritis (RA) accounting for the highest proportion (50.50%). Significant differences were observed in terms of age, gender, body mass index (BMI), disease duration, smoking and family history among patients with different types of inflammatory arthritis. Physical activity and cold exposure were identified as the main predisposing factors for RA, psoriatic arthritis (PsA), osteoarthritis (OA), and ankylosing spondylitis (AS), while alcohol consumption was the most common inducing factor for gout. Hypertension and hyperlipidemia were the primary concomitant diseases in RA, OA, and AS, whereas hyperuricemia and hypertension were mainly associated with gout, psoriasis and diabetes were the most common comorbidities in PsA. Peripheral joints were predominantly affected in PsA, RA, OA, and gout, while axial joints were mainly affected in AS. Methotrexate and leflunomide were the main therapeutic drugs for RA, while biologics were commonly prescribed for PsA and AS. OA and gout patients mainly utilized nonsteroidal anti-inflammatory drugs (NSAIDs).

conclusionPatients with different types of inflammatory arthritis exhibited varying predisposing factors, joint inflammation, concomitant diseases, and medication choices, highlighting the importance of individualized approaches in the clinic. Key Points • 2,693 patients classified and diagnosed with inflammatory arthritis were recruited in this study from 16 Grade-A tertiary hospitals in China between August 2021 and April 2022. • This study analyzed and compared the proportion of patients with different types of arthritis in routine clinical practice in China. • Joint inflammation, comorbidities, and medication choices were assessed among patients with the most common types of arthritis in this study. • This study also provided some epidemiologically relevant information about inflammatory arthritis patients in China.

Indexed as

ArthritisArthritis, PsoriaticArthritis, RheumatoidOsteoarthritisSpondylitis, AnkylosingAdultAgedAntirheumatic AgentsChinaComorbidityFemaleHumansMaleMethotrexateMiddle AgedAntirheumatic AgentsMethotrexateConcomitant diseasesInflammatory arthritisJoint inflammationMedication choicesPredisposing factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.